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Introduction
Although olfactory hallucination or phantosmia could
occur in several neurological and non-neurological condi-
tions, olfactory migrainous hallucination (OMH) is a rare
and probably underestimated phenomenon, involving
about 0.1% of migraine patients [1], and not considered
among the migrainous aura manifestations according to
the International Classification of Headache Disorders,
3th edition (ICHD-III beta version) [2]. Very few clinical
studies on the topic have been published [3]; therefore, the
clinical characterization of OMH is still lacking.
Materials and methods
We report the clinical features of OMH prospectively
collected by a detailed and structured anamnesis
obtained in 5 patients who spontaneously referred the
presence of OMH associated to their headache attacks.
Patients were subsequently followed with a diary for at
least a year. Moreover, the efficacy of the prophylactic
therapy, if suggested, has been recorded.
Results
Five patients (4 females, 1 male) presented with a history
of migraine without aura (MO) (n=4) and with aura (MA)
(n=1) associated with OHM. Mean age at the first evalua-
tion and at headache onset was respectively 42.2 years
(range 25-51) and 17.0 years (range 5-28), while OMH
appeared at a mean age of 34.6 years (range 5-54). In 4
cases, a concomitant primary headache was diagnosed
(MA, n=2; episodic tension-type headache, n=1; primary
stabbing headache, n=1). Physical and neurological exami-
nations, laboratory analyses, neuroimaging and EEG
resulted unremarkable. OMH presented with an average
frequency of once every 3 attacks. Onset and resolution of
phantosmia were sudden in 3 cases and gradual in the
remaining 2, with a mean duration of 10 min. The painful
phase followed the disappearance of OMH in all the cases.
The type of the perceived smell was invariably constant in
9 patients, while one patient reported different phantosmia
for every different attack.
Conclusions
When properly asked, patients are able to describe in
detail the features of their olfactory hallucination. Their
characteristics fulfilled the ICHD-III beta criteria for the
aura symptoms [2]: if these features should find confirma-
tion in further prospective studies, OMH could be consid-
ered similarly to the typical aura manifestations and
included among them in the MA diagnostic criteria in the
appendix of the next ICHD.
Written informed consent to publication was obtained
from the patient(s).
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